05.04.2016
- Results from the just-concluded studies of the Eli Lilly drug candidate evacetrapib by the Cleveland Clinic in Ohio, USA, have underscored other findings that industry watchers...
04.04.2016
- Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...
24.02.2016
- Major drugs firms AstraZeneca, Pfizer and Eli Lilly are among seven of the world’s largest pharmaceutical companies that have joined a new consortium to improve clinical trials for...
16.02.2016
- US drugmaker Eli Lilly has lost the latest round in an ongoing legal fight in the UK over patents relating to the administration of vitamins given alongside its blockbuster lung...
08.12.2015
- US drugmaker Eli Lilly is ending development of its injectable basal insulin peglispro (BIL), a potential treatment for type 1 and type 2 diabetes, to focus on other, more...
05.11.2015
- US drugmaker Eli Lilly plans to expand its research and development headquarters in Indianapolis, Indiana, to the tune of $70 million, adding floor space and a new disciplinary...
22.10.2015
- Six international drugmakers, led by GlaxoSmithKline (GSK) and including Johnson & Johnson, Biogen, Eli Lilly, Pfizer and Takeda, have joined forces with the UK Department of...
19.10.2015
- US drug maker Eli Lilly has discontinued clinical trials with evacetrapib, a potential blockbuster medicine it had hoped to recommend for treatment of high-risk atherosclerotic...
